Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of NVSI-06-08 Booster
NCT05069129Phase 2Unknown
- Sponsor
- Serum Institute of India
- Start
- Oct 2021
- Primary completion
- Dec 2023
- Modality
- Prophylactic Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of NVSI-06-08 in coronavirus disease 2019 (COVID-19), sponsored by Serum Institute of India. Status: unknown.
02
Drugs
NVSI-06-08
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05069129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05069129.